LEFT VENTRICULAR DYSFUNCTION
Clinical trials for LEFT VENTRICULAR DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR DYSFUNCTION trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart pump may boost outcomes in High-Risk angioplasty patients
Disease control OngoingThis study tests whether using the Impella heart pump during a high-risk angioplasty improves symptoms, heart function, and overall health compared to standard care. It involves 1,252 adults with weak hearts and complex coronary artery disease. The goal is to see if the pump redu…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Heart pump may save lives in risky surgeries
Disease control OngoingThis study tests whether using the Impella 5.5 heart pump during and after heart surgery helps patients with very weak hearts. About 100 adults having high-risk heart procedures will receive the pump to support their heart function. The goal is to see if it reduces death, stroke,…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Heart repair stem cell study pulled before it started
Disease control TerminatedThis study aimed to test if stem cells from umbilical cords, delivered through a thin tube into the heart, could safely help people with severe heart damage after a major heart attack. The goal was to improve heart function and reduce complications. However, the study was withdra…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New heart pump trial aims to improve safety in complex surgeries
Disease control OngoingThis study looks at how well the Impella 5.5 heart pump works in people with weak hearts who need high-risk heart surgery. About 123 participants will be followed to see if the pump reduces complications like heart failure, stroke, or death. The goal is to gather more safety and …
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for long COVID heart sufferers: drug combo trial launches
Disease control OngoingThis study tests whether a combination of anti-inflammatory and heart-protecting drugs can reduce symptoms and prevent heart damage in people with Long COVID who have ongoing heart inflammation. About 279 adults with persistent heart-related symptoms and MRI evidence of inflammat…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Heart attack survivors: new study seeks to predict sudden death risk
Knowledge-focused OngoingThis study follows over 5,700 people with coronary artery disease to find blood or ECG markers that could predict sudden cardiac death. The goal is to better identify who needs a defibrillator and who doesn't. Participants have had a heart attack or mild heart muscle weakness, bu…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC